Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1955;12:981-985

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by STORM, O.
Right arrow Articles by HANSEN, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by STORM, O.
Right arrow Articles by HANSEN, A. T.

(Circulation. 1955;12:981.)
© 1955 American Heart Association, Inc.


Mitral Commissurotomy Performed During Anticoagulant Prophylaxis with Dicumarol

OLE STORM M.D.1 ANDERS TYBJÆRG HANSEN M.D.1

1 From the Rigshospitalet, Medical Department B (Head: Prof. E. Warburg, M.D.), Surgical Department D (Head: Prof. E. Husfeldt, M.D.), Surgical Department R (Head: Prof. F. Therkelsen, M.D.), University Hospital of Copenhagen and the Biological Institute of the Carlsberg Foundation (Head: Dr. A Fischer), Copenhagen, Denmark.

Since it is possible to perform major surgical interventions on patients with lowered prothrombin-proconvertin concentration we have selected a group of patients suffering from mitral stenosis for further evaluation of this prophylactic measure. These patients are highly predisposed to thromboembolic complications. The controllable risk of hemorrhage might, therefore, be preferred to the heavy risk of thrombosis. The results of our investigations indicate a decrease in incidents of thromboembolism. No serious risk of bleeding is apparently introduced when an accurate and sensitive method of estimating the prothrombin level is used in the control of the treatment.